Novartis is buying Anthos Therapeutics from Blackstone’s drug development division, as it makes a bet on an experimental drug aimed at preventing strokes in patients with an irregular heart rhythm.
Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), a $15.77 billion market cap company with an "Excellent" financial health rating according to InvestingPro, executed a ...
About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...
Massachusetts General Hospital announced that Tim Andrews recovered well enough from the transplant to leave the hospital a ...
Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the U.S.
A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...
A 66-year-old New Hampshire man received the kidney as part of a small pilot study at Mass General Brigham. United Therapeutics, another developer of gene-edited pig organs, just won FDA approval for ...
The second person ever has received a transplant with a genetically modified pig kidney.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback